总投资近9亿美元！阿斯利康青岛生产基地追加投资1.36亿美元

Group 1 - AstraZeneca announced an additional investment of $136 million to expand the production capacity of its inhalation aerosol facility in Qingdao during the 8th China International Import Expo [1][2] - Following this additional investment, the total investment in the Qingdao facility has reached $886 million [2]